Les bibliothèques scientifiques et les données de la recherche: défis et enjeux

Les données produites lors des activités de recherche sont partie intégrante de l’information scientifique. Traditionnellement, les bibliothèques académiques ont pris en main les activités de gestion des données de recherche (GDR) et les formations auprès des chercheurs. La Suisse, avec un temps de retard sur d’autres pays, lance désormais un projet national, le DLCM, pour créer des solutions adaptées à la gestion des données de recherche tout au long de leur cycle de vie. Elle espère ainsi notamment faire face aux exigences du programme européen Horizon 2020. Dans ce contexte, certains professionnels de l’information, et notamment les bibliothécaires académiques, seront appelés à dispenser des formations à la gestion des données de recherche. Le propos de cette recherche est de fournir des éléments d’analyse pour aider à la prise de décision en vue de prochaines formations de formateurs. A travers une veille sur l’offre internationale de formations à la GDR, nous dressons un panorama analytique de 57 programmes différents ainsi qu’un tableau comparatif synoptique. Un questionnaire destiné aux professionnels de l’information en Suisse a été diffusé, visant à estimer parmi cette population les niveaux d’activités liées à la GDR et les connaissances et compétences déjà acquises ou à développer. Les résultats montrent que les connaissances actuelles sont très hétéroclites, avec des différences parfois extrêmes entre les participants. Néanmoins, la grande majorité d’entre eux a des compétences balbutiantes. Il apparaît que les besoins en formation se dessinent sur un large spectre de thématiques liées à la GDR, plutôt que sur des aspects très précis. 88% des participants estiment qu’ils seront confrontés à la GDR d’ici 5 ans. Des entretiens auprès des collaborateurs responsables du dossier GDR de trois universités romandes (EPFL, UNIGE, UNIL) nous ont permis de déterminer le positionnement de ces dernières en termes de développement de services. La combinaison de ces informations avec celles obtenues à travers l’enquête permet de voir se profiler deux grandes tendances concernant la mise en place de services dans les institutions suisses : il s’agit du développement d’infrastructures et outils et du conseil/formation. Notre recherche aboutit à une esquisse de formation modulaire destinée aux professionnels qui seront en charge de sensibiliser et former les chercheurs et le staff de leurs institutions respectives. Ce canevas de formation comprend trois niveaux, de basique à avancé ; les modules peuvent servir de base pour des workshops, ou, s’ils sont suivis en intégralité, constituer un Certificate of advanced studies en GDR

Mapping Riparian Habitats of Natura 2000 Network (91E0*, 3240) at Individual Tree Level Using UAV Multi-Temporal and Multi-Spectral Data

Riparian habitats provide a series of ecological services vital for the balance of the environment, and are niches and resources for a wide variety of species. Monitoring riparian environments at the intra-habitat level is crucial for assessing and preserving their conservation status, although it is challenging due to their landscape complexity. Unmanned aerial vehicles (UAV) and multi-spectral optical sensors can be used for very high resolution (VHR) monitoring in terms of spectral, spatial, and temporal resolutions. In this contribution, the vegetation species of the riparian habitat (91E0*, 3240 of Natura 2000 network) of North-West Italy were mapped at individual tree (ITD) level using machine learning and a multi-temporal phenology-based approach. Three UAV flights were conducted at the phenological-relevant time of the year (epochs). The data were analyzed using a structure from motion (SfM) approach. The resulting orthomosaics were segmented and classified using a random forest (RF) algorithm. The training dataset was composed of field-collected data, and was oversampled to reduce the effects of unbalancing and size. Three-hundred features were computed considering spectral, textural, and geometric information. Finally, the RF model was cross-validated (leave-one-out). This model was applied to eight scenarios that differed in temporal resolution to assess the role of multi-temporality over the UAV’s VHR optical data. Results showed better performances in multi-epoch phenology-based classification than single-epochs ones, with 0.71 overall accuracy compared to 0.61. Some classes, such as Pinus sylvestris and Betula pendula, are remarkably influenced by the phenology-based multi-temporality: the F1-score increased by 0.3 points by considering three epochs instead of two

Antioxidant and Anti-Inflammatory Effect of Cinnamon (Cinnamomum verum J. Presl) Bark Extract after In Vitro Digestion Simulation

Cinnamon bark is widely used for its organoleptic features in the food context and growing evidence supports its beneficial effect on human health. The market offers an increasingly wide range of food products and supplements enriched with cinnamon extracts which are eliciting beneficial and health-promoting properties. Specifically, the extract of Cinnamomum spp. is rich in antioxidant, anti-inflammatory and anticancer biomolecules. These include widely reported cinnamic acid and some phenolic compounds, such asproanthocyanidins A and B, and kaempferol. These molecules are sensitive to physical-chemical properties (such as pH and temperature) and biological agents that act during gastric digestion, which could impair molecules' bioactivity. Therefore, in this study, the cinnamon's antioxidant and anti-inflammatory bioactivity after simulated digestion was evaluated by analyzing the chemical profile of the pure extract and digested one, as well as the cellular effect in vitro models, such as Caco2 and intestinal barrier. The results showed that the digestive process reduces the total content of polyphenols, especially tannins, while preserving other bioactive compounds such as cinnamic acid. At the functional level, the digested extract maintains an antioxidant and anti-inflammatory effect at the cellular level

Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPD + HF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPD + HF. Patients with COPD + HF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPD + HF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPD + HF for all causes (p = 0.010), respiratory causes (p = 0.006), cardiovascular causes (p = 0.046) and respiratory plus cardiovascular causes (p = 0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population

Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register

Diabetes is an increasing global health burden with the highest prevalence (24.0%) observed in elderly people. Older diabetic adults have a greater risk of hospitalization and several geriatric syndromes than older nondiabetic adults. For these conditions, special care is required in prescribing therapies including anti- diabetes drugs. Aim of this study was to evaluate the appropriateness and the adherence to safety recommendations in the prescriptions of glucose-lowering drugs in hospitalized elderly patients with diabetes. Data for this cross-sectional study were obtained from the REgistro POliterapie-Società Italiana Medicina Interna (REPOSI) that collected clinical information on patients aged ≥ 65 years acutely admitted to Italian internal medicine and geriatric non-intensive care units (ICU) from 2010 up to 2019. Prescription appropriateness was assessed according to the 2019 AGS Beers Criteria and anti-diabetes drug data sheets.Among 5349 patients, 1624 (30.3%) had diagnosis of type 2 diabetes. At admission, 37.7% of diabetic patients received treatment with metformin, 37.3% insulin therapy, 16.4% sulfonylureas, and 11.4% glinides. Surprisingly, only 3.1% of diabetic patients were treated with new classes of anti- diabetes drugs. According to prescription criteria, at admission 15.4% of patients treated with metformin and 2.6% with sulfonylureas received inappropriately these treatments. At discharge, the inappropriateness of metformin therapy decreased (10.2%, P < 0.0001). According to Beers criteria, the inappropriate prescriptions of sulfonylureas raised to 29% both at admission and at discharge. This study shows a poor adherence to current guidelines on diabetes management in hospitalized elderly people with a high prevalence of inappropriate use of sulfonylureas according to the Beers criteria

The “Diabetes Comorbidome”: A Different Way for Health Professionals to Approach the Comorbidity Burden of Diabetes

(1) Background: The disease burden related to diabetes is increasing greatly, particularly in older subjects. A more comprehensive approach towards the assessment and management of diabetes’ comorbidities is necessary. The aim of this study was to implement our previous data identifying and representing the prevalence of the comorbidities, their association with mortality, and the strength of their relationship in hospitalized elderly patients with diabetes, developing, at the same time, a new graphic representation model of the comorbidome called “Diabetes Comorbidome”. (2) Methods: Data were collected from the RePoSi register. Comorbidities, socio-demographic data, severity and comorbidity indexes (Cumulative Illness rating Scale CIRS-SI and CIRS-CI), and functional status (Barthel Index), were recorded. Mortality rates were assessed in hospital and 3 and 12 months after discharge. (3) Results: Of the 4714 hospitalized elderly patients, 1378 had diabetes. The comorbidities distribution showed that arterial hypertension (57.1%), ischemic heart disease (31.4%), chronic renal failure (28.8%), atrial fibrillation (25.6%), and COPD (22.7%), were the more frequent in subjects with diabetes. The graphic comorbidome showed that the strongest predictors of death at in hospital and at the 3-month follow-up were dementia and cancer. At the 1-year follow-up, cancer was the first comorbidity independently associated with mortality. (4) Conclusions: The “Diabetes Comorbidome” represents the perfect instrument for determining the prevalence of comorbidities and the strength of their relationship with risk of death, as well as the need for an effective treatment for improving clinical outcomes

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes

Objective: To describe the prescription pattern of antidiabetic and cardiovascular drugs in a cohort of hospitalized older patients with diabetes. Methods: Patients with diabetes aged 65 years or older hospitalized in internal medicine and/or geriatric wards throughout Italy and enrolled in the REPOSI (REgistro POliterapuie SIMI—Società Italiana di Medicina Interna) registry from 2010 to 2019 and discharged alive were included. Results: Among 1703 patients with diabetes, 1433 (84.2%) were on treatment with at least one antidiabetic drug at hospital admission, mainly prescribed as monotherapy with insulin (28.3%) or metformin (19.2%). The proportion of treated patients decreased at discharge (N = 1309, 76.9%), with a significant reduction over time. Among those prescribed, the proportion of those with insulin alone increased over time (p = 0.0066), while the proportion of those prescribed sulfonylureas decreased (p < 0.0001). Among patients receiving antidiabetic therapy at discharge, 1063 (81.2%) were also prescribed cardiovascular drugs, mainly with an antihypertensive drug alone or in combination (N = 777, 73.1%). Conclusion: The management of older patients with diabetes in a hospital setting is often sub-optimal, as shown by the increasing trend in insulin at discharge, even if an overall improvement has been highlighted by the prevalent decrease in sulfonylureas prescription

Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register

Beta (β)-blockers (BB) are useful in reducing morbidity and mortality in patients with heart failure (HF) and concomitant chronic obstructive pulmonary disease (COPD). Nevertheless, the use of BBs could induce bronchoconstriction due to β2-blockade. For this reason, both the ESC and GOLD guidelines strongly suggest the use of selective β1-BB in patients with HF and COPD. However, low adherence to guidelines was observed in multiple clinical settings. The aim of the study was to investigate the BBs use in older patients affected by HF and COPD, recorded in the REPOSI register. Of 942 patients affected by HF, 47.1% were treated with BBs. The use of BBs was significantly lower in patients with HF and COPD than in patients affected by HF alone, both at admission and at discharge (admission, 36.9% vs. 51.3%; discharge, 38.0% vs. 51.7%). In addition, no further BB users were found at discharge. The probability to being treated with a BB was significantly lower in patients with HF also affected by COPD (adj. OR, 95% CI: 0.50, 0.37-0.67), while the diagnosis of COPD was not associated with the choice of selective β1-BB (adj. OR, 95% CI: 1.33, 0.76-2.34). Despite clear recommendations by clinical guidelines, a significant underuse of BBs was also observed after hospital discharge. In COPD affected patients, physicians unreasonably reject BBs use, rather than choosing a β1-BB. The expected improvement of the BB prescriptions after hospitalization was not observed. A multidisciplinary approach among hospital physicians, general practitioners, and pharmacologists should be carried out for better drug management and adherence to guideline recommendations